BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chevaliez S, Pawlotsky J. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings. Journal of Hepatology 2018;69:916-26. [DOI: 10.1016/j.jhep.2018.05.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Suhail M, Sohrab SS, Kamal M, Azhar EI. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview. Front Oncol 2022;12:913231. [DOI: 10.3389/fonc.2022.913231] [Reference Citation Analysis]
2 Kramvis A, Chang KM, Dandri M, Farci P, Glebe D, Hu J, Janssen HLA, Lau DTY, Penicaud C, Pollicino T, Testoni B, Van Bömmel F, Andrisani O, Beumont-Mauviel M, Block TM, Chan HLY, Cloherty GA, Delaney WE, Geretti AM, Gehring A, Jackson K, Lenz O, Maini MK, Miller V, Protzer U, Yang JC, Yuen MF, Zoulim F, Revill PA. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35859026 DOI: 10.1038/s41575-022-00649-z] [Reference Citation Analysis]
3 Jia JA, Zhang S, Bai X, Fang M, Chen S, Liang X, Zhu S, Wong DK, Zhang A, Feng J, Sun F, Gao C. Sparse logistic regression revealed the associations between HBV PreS quasispecies and hepatocellular carcinoma. Virol J 2022;19:114. [PMID: 35765099 DOI: 10.1186/s12985-022-01836-9] [Reference Citation Analysis]
4 Lim HJ, Saha T, Tey BT, Tan WS, Hassan SS, Ooi CW. Quartz crystal microbalance-based biosensing of hepatitis B antigen using a molecularly imprinted polydopamine film. Talanta 2022;249:123659. [PMID: 35728452 DOI: 10.1016/j.talanta.2022.123659] [Reference Citation Analysis]
5 Ceesay A, Lemoine M, Cohen D, Chemin I, Ndow G. Clinical utility of the 'Determine HBsAg' Point-of-Care Test for Diagnosis of Hepatitis B Surface Antigen in Africa. Expert Rev Mol Diagn 2022. [PMID: 35574686 DOI: 10.1080/14737159.2022.2076595] [Reference Citation Analysis]
6 Santana GM, Silva AKS, Foguel MV, Dutra RF. An ultrasensitive electrochemical immunosensor for hepatitis C antibodies based on one-step-eletrosynthetized polypyrrole–graphene nanocomposite. J Mater Sci. [DOI: 10.1007/s10853-022-06992-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gupta A, Ramachandran K, Paul D, Gupta E. Evaluation of three different rapid card tests for the detection of hepatitis B surface antigen. Trop Doct 2022;:494755211069712. [PMID: 35072566 DOI: 10.1177/00494755211069712] [Reference Citation Analysis]
8 Loarec A, Nguyen A, Molfino L, Chissano M, Madeira N, Rusch B, Staderini N, Couto A, Ciglenecki I, Antabak NT. Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique. Bull World Health Organ 2022;100:60-9. [PMID: 35017758 DOI: 10.2471/BLT.20.281311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kramvis A. Challenges for hepatitis B virus cure in resource-limited settings in sub-Saharan Africa. Curr Opin HIV AIDS 2020;15:185-92. [PMID: 32141888 DOI: 10.1097/COH.0000000000000619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Leroy V, Chevaliez S, Decraecker M, Roulot D, Nana J, Asselah T, Causse X, Durantel D, Thibaut V, Ganne-Carrié N, Bureau C, de Lédinghen V, Bourlière M. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS. Clin Res Hepatol Gastroenterol 2021;:101773. [PMID: 34332134 DOI: 10.1016/j.clinre.2021.101773] [Reference Citation Analysis]
11 Dunn D, Price H, Vudriko T, Kityo C, Musoro G, Hakim J, Gilks C, Kaleebu P, Pillay D, Gilson R; DART Virology Group. New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings. J Acquir Immune Defic Syndr 2021;86:98-103. [PMID: 33306565 DOI: 10.1097/QAI.0000000000002517] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chang TS, Chang KC, Chen WM, Hsu NT, Lee CY, Lin YC, Huang WC, Chiu WN, Hu JH, Huang TJ, Chen MY, Lu SN. Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study. BMJ Open 2021;11:e046115. [PMID: 34233977 DOI: 10.1136/bmjopen-2020-046115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhang W, Aryan M, Qian S, Cabrera R, Liu X. A Focused Review on Recent Advances in the Diagnosis and Treatment of Viral Hepatitis. Gastroenterology Res 2021;14:139-56. [PMID: 34267829 DOI: 10.14740/gr1405] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Stockdale AJ, Silungwe NM, Shawa IT, Kreuels B, Gordon MA, Geretti AM. Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi. BMC Infect Dis 2021;21:487. [PMID: 34044776 DOI: 10.1186/s12879-021-06134-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Antipchik M, Korzhikova-Vlakh E, Polyakov D, Tarasenko I, Reut J, Öpik A, Syritski V. An electrochemical biosensor for direct detection of hepatitis C virus. Anal Biochem 2021;624:114196. [PMID: 33848501 DOI: 10.1016/j.ab.2021.114196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Morales-Arraez D, Hernández-Bustabad A, Medina-Alonso MJ, Santiago-Gutiérrez LG, García-Gil S, Diaz-Flores F, Pérez-Pérez V, Nazco J, Fernandez de Rota Martin P, Gutiérrez F, Hernández-Guerra M. Telemedicine and decentralized hepatitis C treatment as a strategy to enhance retention in care among people attending drug treatment centres. Int J Drug Policy 2021;94:103235. [PMID: 33838399 DOI: 10.1016/j.drugpo.2021.103235] [Reference Citation Analysis]
17 Tonen-Wolyec S, Djang'eing'a RM, Batina-Agasa S, Kayembe Tshilumba C, Muwonga Masidi J, Hayette MP, Bélec L. Self-testing for HIV, HBV, and HCV using finger-stick whole-blood multiplex immunochromatographic rapid test: A pilot feasibility study in sub-Saharan Africa. PLoS One 2021;16:e0249701. [PMID: 33836036 DOI: 10.1371/journal.pone.0249701] [Reference Citation Analysis]
18 Tyas AA, Raeni SF, Sakti SP, Sabarudin A. Recent Advances of Hepatitis B Detection towards Paper-Based Analytical Devices. ScientificWorldJournal 2021;2021:6643573. [PMID: 33727897 DOI: 10.1155/2021/6643573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lazarus JV, Picchio CA, Guy D, Aleman S, James C, Nava FA, Øvrehus A, Turnes J, Ward JW, Ustianowski A. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy. Clin Res Hepatol Gastroenterol 2021;45:101564. [PMID: 33740477 DOI: 10.1016/j.clinre.2020.11.001] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
20 Carrasco T, Barquín D, Ndarabu A, Fernández-Alonso M, Rubio-Garrido M, Carlos S, Makonda B, Holguín Á, Reina G. HCV Diagnosis and Sequencing Using Dried Blood Spots from Patients in Kinshasa (DRC): A Tool to Achieve WHO 2030 Targets. Diagnostics (Basel) 2021;11:522. [PMID: 33804260 DOI: 10.3390/diagnostics11030522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Velásquez-Orozco F, Rando-Segura A, Martínez-Camprecios J, Salmeron P, Najarro-Centeno A, Esteban À, Quer J, Buti M, Pumarola-Suñe T, Rodríguez-Frías F. Utility of the Cobas® Plasma Separation Card as a Sample Collection Device for Serological and Virological Diagnosis of Hepatitis C Virus Infection. Diagnostics (Basel) 2021;11:473. [PMID: 33800211 DOI: 10.3390/diagnostics11030473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Roger S, Ducancelle A, Le Guillou-Guillemette H, Gaudy C, Lunel F. HCV virology and diagnosis. Clin Res Hepatol Gastroenterol 2021;45:101626. [PMID: 33636428 DOI: 10.1016/j.clinre.2021.101626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Narayanamurthy V, Jeroish ZE, Bhuvaneshwari KS, Samsuri F. Hepatitis C virus (HCV) diagnosis via microfluidics. Anal Methods 2021;13:740-63. [PMID: 33511975 DOI: 10.1039/d0ay02045a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Harrington PR, Komatsu TE, Sun H, Naeger LK. Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic Assays. Clin Infect Dis 2020;70:327-30. [PMID: 31075159 DOI: 10.1093/cid/ciz385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Martínez-Campreciós J, Rando-Segura A, Buti M, Rodrigo-Velásquez F, Riveiro-Barciela M, Barreira-Díaz A, Álvarez-López P, Salmerón P, Palom A, Tabernero D, Palomo N, Nindia A, Barbosa G, López E, Ferreira V, Saiago N, Kuchta A, Ferrer-Costa R, Esteban R, Molina I, Rodríguez-Frías F. Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis. J Virol Methods 2021;289:114039. [PMID: 33338545 DOI: 10.1016/j.jviromet.2020.114039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Pawlotsky J, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G, Marra F, Puoti M, Wedemeyer H. EASL recommendations on treatment of hepatitis C: Final update of the series☆. Journal of Hepatology 2020;73:1170-218. [DOI: 10.1016/j.jhep.2020.08.018] [Cited by in Crossref: 113] [Cited by in F6Publishing: 102] [Article Influence: 56.5] [Reference Citation Analysis]
27 Xiao Y, Thompson AJ, Howell J. Point-of-Care Tests for Hepatitis B: An Overview. Cells 2020;9:E2233. [PMID: 33023265 DOI: 10.3390/cells9102233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
28 Inci F, Karaaslan MG, Mataji-kojouri A, Shah PA, Saylan Y, Zeng Y, Avadhani A, Sinclair R, Lau DT, Demirci U. Enhancing the nanoplasmonic signal by a nanoparticle sandwiching strategy to detect viruses. Applied Materials Today 2020;20:100709. [DOI: 10.1016/j.apmt.2020.100709] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 9.5] [Reference Citation Analysis]
29 Sanou AM, Toyé R, Kagoné T, Nikiéma A, Testa J, Sakandé J, Sangaré L, Tarnagda Z, Kania D. Analytical performance of eight rapid point-of-care tests routinely used for the detection of HBsAg in Burkina Faso: A cross-sectional study. Journal of Clinical Virology 2020;129:104546. [DOI: 10.1016/j.jcv.2020.104546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Pawlotsky J, Ramers CB, Dillon JF, Feld JJ, Lazarus JV. Simplification of Care for Chronic Hepatitis C Virus Infection. Semin Liver Dis 2020;40:392-402. [DOI: 10.1055/s-0040-1713657] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
31 Palayew A, Razavi H, Hutchinson SJ, Cooke GS, Lazarus JV. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C? Lancet Gastroenterol Hepatol 2020;5:948-53. [PMID: 32730784 DOI: 10.1016/S2468-1253(20)30011-X] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
32 Guingané AN, Bougouma A, Sombié R, King R, Nagot N, Meda N, Van de Perre P, Tuaillon E. Identifying gaps across the cascade of care for the prevention of HBV mother-to-child transmission in Burkina Faso: Findings from the real world. Liver Int 2020;40:2367-76. [PMID: 32633864 DOI: 10.1111/liv.14592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Graham CS. The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection. Clin Liver Dis (Hoboken). 2020;16:16-19. [PMID: 32714518 DOI: 10.1002/cld.925] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
34 Roger S, Lefeuvre C, Grison M, Ducancelle A, Lunel-Fabiani F, Pivert A, Le Guillou-Guillemette H. Evaluation of the Aptima™ HBV Quant Dx assay for semi-quantitative HBV viral load from dried blood spots. J Clin Virol 2020;129:104524. [PMID: 32629186 DOI: 10.1016/j.jcv.2020.104524] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Jackson K, Gish RG. Point of Care Diagnostic Testing for Hepatitis B Virus. Curr Hepatology Rep 2020;19:245-53. [DOI: 10.1007/s11901-020-00531-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Antipchik M, Polyakov D, Sinitsyna E, Dzhuzha A, Shavlovsky M, Korzhikova-Vlakh E, Tennikova T. Towards the Development of a 3-D Biochip for the Detection of Hepatitis C Virus. Sensors (Basel) 2020;20:E2719. [PMID: 32397590 DOI: 10.3390/s20092719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
37 Kretzschmar MEE, van der Sande MAB. Hepatitis B prevention: Can we learn from the response to HIV/AIDS? PLoS Med 2020;17:e1003109. [PMID: 32315316 DOI: 10.1371/journal.pmed.1003109] [Reference Citation Analysis]
38 Azad AR, Zargar M, Zolfaghari MR, Mohammadbeigi A. The Prevalence of Hepatitis B and D Viruses and Evaluating YMDD Mutation in HBV-Suspected Patients in Qom Province, Iran. Jundishapur J Microbiol 2020;13. [DOI: 10.5812/jjm.100038] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Taye BW. A Path to Ending Hepatitis C in Ethiopia: A Phased Public Health Approach to Achieve Micro-Elimination. Am J Trop Med Hyg 2019;101:963-72. [PMID: 31516107 DOI: 10.4269/ajtmh.19-0295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Rodríguez-Tajes S, Domínguez Á, Carrión JA, Buti M, Quer JC, Morillas RM, López C, Torras X, Baliellas C, Vergara M, Forner M, Zaragoza N, Salò J, Rigau J, Caballeria L, Mariño Z, Janè M, Colom J, Forns X, Lens S. Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals. J Gastroenterol Hepatol 2020;35:1570-8. [PMID: 31957902 DOI: 10.1111/jgh.14984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
41 Crespo J, Albillos A, Buti M, Calleja JL, Garcia-samaniego J, Hernández-guerra M, Serrano T, Turnes J, Acín E, Berenguer J, Berenguer M, Colom J, Fernández I, Fernández Rodríguez C, Forns X, García F, Granados R, Lazarus J, Molero JM, Molina E, Pérez Escanilla F, Pineda JA, Rodríguez M, Romero M, Roncero C, Saiz de la Hoya P, Sánchez Antolín G. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Gastroenterología y Hepatología (English Edition) 2019;42:579-92. [DOI: 10.1016/j.gastre.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
42 Brouard C, Saboni L, Gautier A, Chevaliez S, Rahib D, Richard JB, Barin F, Larsen C, Sommen C, Pillonel J, Delarocque-Astagneau E, Lydié N, Lot F; 2016 Health Barometer Group. HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy. BMC Infect Dis 2019;19:896. [PMID: 31660879 DOI: 10.1186/s12879-019-4493-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
43 Crespo J, Albillos A, Buti M, Calleja JL, García-Samaniego J, Hernández-Guerra M, Serrano T, Turnes J, Acín E, Berenguer J, Berenguer M, Colom J, Fernández I, Fernández Rodríguez C, Forns X, García F, Rafael Granados, Lazarus JV, Molero JM, Molina E, Pérez Escanilla F, Pineda JA, Rodríguez M, Romero M, Roncero C, Saiz de la Hoya P, Sánchez Antolín G. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Gastroenterol Hepatol 2019;42:579-92. [PMID: 31594683 DOI: 10.1016/j.gastrohep.2019.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
44 Lazarus JV, Pericàs JM, Picchio C, Cernosa J, Hoekstra M, Luhmann N, Maticic M, Read P, Robinson EM, Dillon JF. We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade. J Intern Med 2019;286:503-25. [PMID: 31472002 DOI: 10.1111/joim.12972] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 11.7] [Reference Citation Analysis]
45 Nayagam S, Thursz M. Strategies for Global Elimination of Chronic HBV Infection: 2019 Update. Curr Hepatology Rep 2019;18:300-9. [DOI: 10.1007/s11901-019-00478-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
46 Wang JH, Chen CH, Chang CM, Feng WC, Lee CY, Lu SN. Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan. J Formos Med Assoc 2020;119:504-8. [PMID: 31350109 DOI: 10.1016/j.jfma.2019.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
47 Wang J, Qu B, Zhang F, Zhang C, Deng W, Dao Thi VL, Xia Y. Stem Cell-Derived Hepatocyte-Like Cells as Model for Viral Hepatitis Research. Stem Cells Int 2019;2019:9605252. [PMID: 31281392 DOI: 10.1155/2019/9605252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
48 Chhatwal J, Chen Q, Wang X, Ayer T, Zhuo Y, Janjua NZ, Kanwal F. Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan. JAMA Netw Open 2019;2:e193613. [PMID: 31074817 DOI: 10.1001/jamanetworkopen.2019.3613] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
49 Vaux S, Chevaliez S, Saboni L, Sauvage C, Sommen C, Barin F, Alexandre A, Jauffret-Roustide M, Lot F, Velter A; ANRS-Prevagay group. Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015. BMC Infect Dis 2019;19:315. [PMID: 30971207 DOI: 10.1186/s12879-019-3945-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
50 Cortesi PA, Barca R, Giudicatti G, Mossini S, Ciaccio A, Iannazzo S, Micale M, Cesana G, Mantovani LG. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era. Aliment Pharmacol Ther 2019;49:1126-33. [PMID: 30843268 DOI: 10.1111/apt.15201] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
51 Barbosa JDAB, de França CA, Gouveia JJDS, Gouveia GV, da Costa MM, de Oliveira HP. Eudragit E100/poly(ethylene oxide) electrospun fibers for DNA removal from aqueous solution. J Appl Polym Sci 2019;136:47479. [DOI: 10.1002/app.47479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
52 Coffin CS, Zhou K, Terrault NA. New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection. Gastroenterology 2019;156:355-368.e3. [PMID: 30472225 DOI: 10.1053/j.gastro.2018.11.037] [Cited by in Crossref: 35] [Cited by in F6Publishing: 51] [Article Influence: 8.8] [Reference Citation Analysis]